VICT3R https://validator.w3.org/feed/docs/rss2.html VICT3R Holds 3rd Consortium Meeting in Barcelona Home EMA Qualification Opinion on VICT3R Context of Use I Open for Public Consultation Training A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary Data Never-ending Acronym Madness: Proposing a harmonized definition for NAMs VICT3R Community Interfacility Variations in Blood Chemistry Parameters and Their Implications for Virtual Control Group Construction Exploration of virtual control groups and Bayesian approaches for rat fertility studies Delivering regulatory impact from consortium-based projects Vera Rogiers STP Town Hall Discussion on the Use of Virtual Control Groups in Nonclinical Toxicity Studies Karolina Kopańska Public IT Tools Work Packages Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groups Facts & Figures More Minds, More Impact − New Members Join the VICT3R Community The age of animal experiments is waning. Where will science go next? Guiding principles of good AI practice in drug development Non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation – Scientific guideline The need for epigenotoxicity testing The long way from raw data to NAM-based information: Overview on data layers and processing steps Video library Labcorp Collaboration at the heart of VICT3R: highlights from the 4th Consortium Meeting Virtual Control Groups in Nonclinical Research: A Re-analysis of 20 Studies Using Virtual Control Group Data GlaxoSmithKline Research & Development Limited Integrative Data Science in Drug Safety Research: Experiences, Challenges, and Perspectives BSL Bioservice Scientific Laboratories Munich GmbH Charles River Laboratories International Inc. Heinz Schwerdtfeger Scantox A/S Statistical applications of virtual control groups to nonrodent animal toxicity studies: An initial evaluation CAATevents gGmbH Scientific and Regulatory Policy Committee Points to Consider: Proposal and Recommendations to Reduce Euthanasia of Control Nonhuman Primates in Nonclinical Toxicity Studies Building a Roadmap for AI-Enabled Human and Environmental Health Protection Servier – R&D Institute Paris-Saclay Use and reporting of historical control data for regulatory studies Using pre-existing control data to set expectations in preclinical studies Innovative Medicines Initiative public–private partnerships to enhance translational safety VICT3R: Virtually Speaking Webinar Series – Conversations Driving Change in Safety Science Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation Nadège Le Roux Guillemette Duchateau-Nguyen Armelle Grevot Mathieu Vinken Perspectives on Implementing Virtual Control Groups in Developmental and Reproductive Toxicity Studies Zoetis Belgium SA VICT3R Featured in the ‘Lab of Tomorrow’ Video Series